|
|
||||||||
Case reports |
a Nuclear Medicine Department, Hôpital Haut-Lévèque, Bordeaux Heart University Hospital, Avenue de Magellan, 33604 Bordeaux-Pessac, France
b Department of Cardio-Vascular Surgery, Hôpital Haut-Lévèque, Bordeaux Heart University Hospital, Avenue de Magellan, 33604 Bordeaux-Pessac, France
c Department of Echocardiography, Hôpital Haut-Lévèque, Bordeaux Heart University Hospital, Avenue de Magellan, 33604 Bordeaux-Pessac, France
d Heart Failure Unit, Hôpital Haut-Lévèque, Bordeaux Heart University Hospital, Avenue de Magellan, 33604 Bordeaux-Pessac, France
Received 31 May 2007; received in revised form 21 August 2007; accepted 22 August 2007.
* Corresponding author. Address: Department of Cardio-Vascular Surgery, Hôpital Haut Lévèque, Avenue de Magellan, 33604 Bordeaux-Pessac, France. Tel.: +33 5 57 65 64 37; fax: +33 5 57 65 81 57. (Email: louis.labrousse{at}chu-bordeaux.fr).
Cardiac support device implantation is a new and promising therapy for refractory heart failure. If functional and echocardiographic modifications have largely been reported following this procedure, there is a paucity of information in the clinical setting about cellular abnormalities modifications during the reverse remodeling process. We report for the first time a clinical measurement of cardiac sympathetic function using 123I-MIBG scintigraphy following cardiac support device implantation.
Key Words: Heart failure Surgery Sympathetic activity
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |